Clinical Trial Update: ProMRI AFFIRM Study of the EVIA/ENTOVIS Pacemaker With Safio S Pacemaker Leads

View source ↗

Summary

The ProMRI AFFIRM study evaluating Biotronik's EVIA/ENTOVIS pacemaker with Safio S leads has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: Biotronik SE & Co. KG | Conditions: Cardiac Disease | Status: COMPLETED